Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,62 USD | +3,12% | -9,59% | +9,48% |
25/04 | Shareholder Capital vraagt raad van bestuur Vanda Pharma om bod Future Pak te heroverwegen | RE |
22/04 | Hooggerechtshof verwerpt zaak Vanda Pharmaceuticals over octrooien op slaapmiddelen | RE |
Omzet 2022 | 254 mln. 238 mln. | Omzet 2023 | 193 mln. 180 mln. | Marktkapitalisatie | 243 mln. 227 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 6 mln. 5,61 mln. | Nettowinst (verlies) 2023 | 2 mln. 1,87 mln. | EV/omzet 2022 | -0,15 x |
Nettoliquiditeiten 2022 | 456 mln. 426 mln. | Nettoliquiditeiten 2023 | 379 mln. 354 mln. | EV/omzet 2023 | -0,71 x |
K/w-verhouding 2022 |
67,2
x | K/w-verhouding 2023 |
106
x | Werknemers | 203 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 94,79% |
Recentste transcriptie over Vanda Pharmaceuticals Inc.
1 dag | +3,13% | ||
1 week | -9,59% | ||
Lopende maand | +12,41% | ||
1 maand | +18,77% | ||
3 maanden | +23,20% | ||
6 maanden | +11,33% | ||
Lopend jaar | +9,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 64 | 01-11-02 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 01-12-12 |
Scott Howell
HRO | Human Resources Officer | - | 01-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 01-12-05 |
Chief Executive Officer | 64 | 01-11-02 | |
Director/Board Member | 72 | 14-02-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.34% | 29 M€ | -4,33% | ||
0.22% | 27 M€ | -5,03% | - | |
0.05% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 4,62 | +3,12% | 821 939 |
25-04-24 | 4,48 | -1,75% | 923 301 |
24-04-24 | 4,56 | -1,51% | 1 458 632 |
23-04-24 | 4,63 | -3,54% | 1 371 417 |
22-04-24 | 4,8 | -6,07% | 2 114 924 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+9,48% | 266 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |